Perspective Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Perspective Therapeutics, Inc. (CATX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018
Operating Activities
Net Income-79.28-46.51-7.27-3.39-3.45-5.14-6.70
Depreciation & Amortization2.310.710.280.150.190.190.13
Deferred Income Tax-2.10-2.650.000.000.000.000.00
Stock Based Compensation5.393.141.090.390.000.000.00
Change in Working Capital0.002.56-1.85-0.07-1.12-0.480.22
Change in Accounts Receivable1.050.200.410.030.000.000.00
Change in Inventory0.010.36-2.67-0.270.000.000.00
Change in Accounts Payable1.891.570.240.080.000.000.00
Change in Other Working Capital0.000.790.180.070.000.000.00
Other Operating Activities55.39-2.240.000.070.740.410.03
Net Cash from Operating Activities-18.29-36.91-7.71-2.84-3.64-5.05-5.71
Investing Activities
Capital Expenditures-54.41-1.07-0.27-0.380.290.46-0.34
Acquisitions0.002.700.000.000.000.000.00
Purchases of Investments-243.5122.76-22.690.000.000.000.00
Sales/Maturities of Investments0.0022.760.000.000.000.832.21
Other Investing Activities78.99-0.02-0.02-0.030.000.00-0.02
Net Cash from Investing Activities-218.9324.37-0.28-0.41-0.290.401.86
Financing Activities
Debt Repayment0.00-0.070.000.000.000.000.00
Common Stock Issued275.810.920.0664.160.000.000.48
Dividends Paid0.000.000.00-0.010.010.01-0.01
Other Financing Activities289.39-0.070.000.005.510.000.00
Net Cash from Financing Activities289.390.790.0664.680.997.370.52
Summary
Net Change in Cash52.16-11.76-7.9461.44-2.932.73-3.33
Cash at Beginning of Period9.4221.1864.012.575.512.786.11
Cash at End of Period61.589.4256.0764.015.512.782.78
Free Cash Flow-72.71-37.99-7.98-3.22-3.93-5.47-6.05
Supplemental Disclosures
Interest Paid0.000.080.000.000.000.000.00